Internet of Medical Things-Based COVID-19 Detection in CT Images Fused with Fuzzy Ensemble and Transfer Learning Models

• Published in: New generation computing 2022, Vol.40 (4), p.1125-1141
• Main Authors: Mahanty, Chandrakanta, Kumar, Raghvendra, Patro, S. Gopal Krishna
• Format: Article
• Language: English
• Subjects: Accuracy; Artificial Intelligence; Cloud computing; Computed tomography; Computer Hardware; Computer Science; Computer Systems Organization and Communication Networks; Coronaviruses; COVID-19; Health care; Image classification; Internet of medical things; Learning; Medical electronics; Medical imaging; Patients; Software Engineering/Programming and Operating Systems; Viral diseases
• ISSN: 0288-3635; 1882-7055
• DOI: 10.1007/s00354-022-00176-0

One of the most difficult research areas in today's healthcare industry to combat the coronavirus pandemic is accurate COVID-19 detection. Because of its low infection miss rate and high sensitivity, chest computed tomography (CT) imaging has been recommended as a viable technique for COVID-19 diagnosis in a number of recent clinical investigations. This article presents an Internet of Medical Things (IoMT)-based platform for improving and speeding up COVID-19 identification. Clinical devices are connected to network resources in the suggested IoMT platform using cloud computing. The method enables patients and healthcare experts to work together in real time to diagnose and treat COVID-19, potentially saving time and effort for both patients and physicians. In this paper, we introduce a technique for classifying chest CT scan images into COVID, pneumonia, and normal classes that use a Sugeno fuzzy integral ensemble across three transfer learning models, namely SqueezeNet, DenseNet-201, and MobileNetV2. The suggested fuzzy ensemble techniques outperform each individual transfer learning methodology as well as trainable ensemble strategies in terms of accuracy. The suggested MobileNetV2 fused with Sugeno fuzzy integral ensemble model has a 99.15% accuracy rate. In the present research, this framework was utilized to identify COVID-19, but it may also be implemented and used for medical imaging analyses of other disorders.